Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1550 of 3284 entries
View as:

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT06307652 Org: User:
Start: 04/12/24 End: 06/11/27 Due: 06/11/28

Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins

Phase: N/A Priority: Normal
NCT ID: NCT02974244 Org: User:
Start: 10/28/14 End: 10/28/14 Due: 10/28/15

FASENRA Regulatory Postmarketing Surveillance in Korea

Phase: N/A Priority: Normal
NCT ID: NCT05091333 Org: User:
Start: 03/11/22 End: 03/06/25 Due: 03/06/26

Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids

Phase: N/A Priority: Normal
NCT ID: NCT04643158 Org: User:
Start: 03/12/21 End: 07/20/23 Due: 07/20/24

Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT01165268 Org: User:
Start: 08/31/10 End: 12/31/10 Due: 12/31/11

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Phase: N/A Priority: Normal
NCT ID: NCT02155660 Org: User:
Start: 06/25/14 End: 04/09/18 Due: 04/09/19

A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS)

Phase: N/A Priority: Normal
NCT ID: NCT03934333 Org: User:
Start: 05/16/19 End: 09/10/19 Due: 09/10/20

SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

Phase: N/A Priority: Normal
NCT ID: NCT02543476 Org: User:
Start: 09/16/15 End: 11/14/16 Due: 11/14/17

Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)

Phase: N/A Priority: Normal
NCT ID: NCT00779506 Org: User:
Start: 11/30/08 End: 07/31/09 Due: 07/31/10

An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00643851 Org: User:
Start: 06/30/08 End: 08/31/09 Due: 08/31/10

To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT03658213 Org: User:
Start: 03/31/20 End: 11/04/21 Due: 11/04/22

Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427

Phase: N/A Priority: Normal
NCT ID: NCT04630067 Org: User:
Start: 11/17/20 End: 09/14/22 Due: 09/14/23

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Elarekibep in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05794672 Org: User:
Start: 04/11/23 End: 07/08/23 Due: 07/08/24

New Nasal Applicator / New Formulation - User Study

Phase: N/A Priority: Normal
NCT ID: NCT00641979 Org: User:
Start: 04/30/02 End: 08/31/02 Due: 08/31/03

Risk of Hospitalized Infections Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01086306 Org: User:
Start: 01/31/10 End: 12/31/15 Due: 12/31/16

AZD6423 SAD/MAD Study in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01926366 Org: User:
Start: 09/30/13 End: 03/31/14 Due: 03/31/15

Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)

Phase: N/A Priority: Normal
NCT ID: NCT00690612 Org: User:
Start: 09/30/07 End: 09/30/09 Due: 09/30/10

AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)

Phase: N/A Priority: Normal
NCT ID: NCT00240331 Org: User:
Start: 01/31/03 End: 10/31/08 Due: 10/31/09

A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and Allopurinol

Phase: N/A Priority: Normal
NCT ID: NCT04550234 Org: User:
Start: 04/13/21 End: 07/15/21 Due: 07/15/22

AZD1419 Ph2a Study

Phase: N/A Priority: Normal
NCT ID: NCT02898662 Org: User:
Start: 10/12/16 End: 09/25/18 Due: 09/25/19

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00090324 Org: User:
Start: 09/30/04 End: 06/30/07 Due: 06/30/08

Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E

Phase: N/A Priority: Normal
NCT ID: NCT00761501 Org: User:
Start: 09/30/08 End: 12/31/08 Due: 12/31/09

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)

Phase: N/A Priority: Normal
NCT ID: NCT00246935 Org: User:
Start: 05/31/05 End: 10/31/07 Due: 10/31/08

Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02573155 Org: User:
Start: 10/31/15 End: 08/31/16 Due: 08/31/17

Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01060059 Org: User:
Start: 04/30/10 End: 05/31/12 Due: 05/31/13